Effect of dipeptidyl peptidase-4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus.

Young ChoiSeung-Hyun KoKiyuk ChangKi Dong YooSang-Hyun Ihm
Published in: Journal of diabetes (2023)
Add-on DPP-4i therapy would be beneficial in preventing coronary artery disease progression in patients with T2DM receiving insulin therapy.